Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-06

Clinical Trial Update: Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing potassium-titanyl phosphate (KTP) laser alone versus KTP laser with ivermectin cream for facial rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium-titanyl Phosphate (KTP) Laser
  • ivermectin cream (ivermectin)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Rosacea | Phase 2 | Status: COMPLETED